<DOC>
	<DOCNO>NCT00551382</DOCNO>
	<brief_summary>Viral upper respiratory tract infection ( URI ) one common diseases among toddler pre-school children.Complete effective prevention measure URI currently unavailable . Montelukast ( Singulair ) selective leukotriene-receptor antagonist inhibits cysteinyl leukotriene 1 receptor . It well tolerate safe even young child . Montelukast effective treatment asthma ( allergic rhinitis 1 year age . Infections viruses cause URI Influenza A , Rhinovirus respiratory syncitial virus increase leukotriens level nasal secretion . Therefore , one may postulate leukotriens inhibitor may reduce symptom URI . However effect montelukast treatment non-specific cough properly study study effect montelukast prevention URI . Hypothesis : Prophylactic treatment Montelukast reduce incidence severity upper respiratory infection child .</brief_summary>
	<brief_title>Montelukast Prophylaxis Upper Respiratory Tract Infections Children : Randomised , Double-blind , Placebo-controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Children 1 5 year old without significant health problem . A previous history wheezing ( require treatment bronchodilator last 3 month one treatment last year ) Hospital admission due reactive air way disease Prophylactic use montelukast steroid Chronic cardiac respiratory disease Presence acute respiratory tract infection within 7 day consideration study History allergic Rhinitis Children receive chronic medication kind Known allergy montelukast Inability get inform consent legal guardian .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Montelukast</keyword>
	<keyword>Upper respiratory tract infection</keyword>
	<keyword>leukotriene</keyword>
	<keyword>Children</keyword>
</DOC>